ISO 9001:2015 Certified
Live Customer Support
4.5/5 on Trustpilot
100% Quality Guarantee

Concizumab Biosimilar - Anti-TFPI Antibody - BSA and Azide free (A338740)

$456

Humanized monoclonal antibody to TFPI. Research grade Concizumab biosimilar for ELISA, Flow Cytometry, Functional Studies and in vivo Research.

Shipping Information

$40
Dispatched from St. Louis, MO.
Lead Time: 7-10 business days.
Name
Concizumab Biosimilar - Anti-TFPI Antibody - BSA and Azide free
Description
Humanized monoclonal antibody to TFPI. Research grade Concizumab biosimilar.
Applications
ELISA, Flow Cytometry, Functional Studies, in vivo Research
Reactivity
Human
Host
Humanized
Clonality
Monoclonal
Isotype
IgG4
Conjugate

Unconjugated

Purity
The purity of this Biosimilar is >95%, as determined by SDS-PAGE.
Product Form
Liquid
Formulation
Supplied in 0.01M Phosphate Buffered Saline, pH 7.4.
Storage
Shipped at 4°C. Upon delivery store at 4°C for short-term use (1-2 weeks) or aliquot and store at -20°C for long-term use (up to 12 months).
Synonyms
EPI, Extrinsic pathway inhibitor, LACI, Lipoprotein-associated coagulation inhibitor, TFPI1, Tissue factor pathway inhibitor
Disclaimer
This product is for research use only. It is not intended for diagnostic or therapeutic use.
Publishing research using Concizumab Biosimilar - Anti-TFPI Antibody - BSA and Azide free (A338740)? Please let us know so that we can list the citation on this page.

Alternative products to Concizumab Biosimilar - Anti-TFPI Antibody - BSA and Azide free (A338740)

Proteins predicted to interact with TFPI

Predicted protein interactions based upon String database. Revelancy score correlates with probability of interaction.
99.9% Relevancy Score
99.9% Relevancy Score
99.5% Relevancy Score
96.3% Relevancy Score
94% Relevancy Score
93.9% Relevancy Score
88.4% Relevancy Score
86% Relevancy Score
81.5% Relevancy Score